Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Freeline Therapeutics Holdings Plc

FRLN
Current price
6.33 USD +0.07 USD (+1.12%)
Last closed 6.23 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 27 150 090 USD
Yield for 12 month +956.76 %
Week
Month
Year
FRLN
21.11.2021 - 28.11.2021

Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. Address: Stevenage Bioscience Catalyst, Stevenage, United Kingdom, SG1 2FX

Analytics

WallStreet Target Price

13.25 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+617 000 USD

Last Quarter

Current Year

Last Year

Current Quarter

+617 000 USD

Last Quarter

Key Figures FRLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -75 692 000 USD
Operating Margin TTM -2842.14 %
PE Ratio
Return On Assets TTM -42.91 %
PEG Ratio
Return On Equity TTM -80.12 %
Wall Street Target Price 13.25 USD
Revenue TTM 617 000 USD
Book Value 9.64 USD
Revenue Per Share TTM 0.14 USD
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings Share -11.7 USD
Diluted Eps TTM -11.7 USD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics FRLN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History FRLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 12.05.2023
Dividend Date

Stock Valuation FRLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.7327
Price Sales TTM 44.0034
Enterprise Value EBITDA -0.023
Price Book MRQ 0.9038

Financials FRLN

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators FRLN

For 52 weeks

2.11 USD 10.2 USD
50 Day MA 4.82 USD
Shares Short Prior Month 142 295
200 Day MA 4.66 USD
Short Ratio 0.27
Shares Short 101 715
Short Percent 0.61 %